Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma

Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma

Submitted by admin on June 16, 2023 - 9:46am
Source: 
BioSpace
News Tags: 
Tessa Therapeutics
CAR-T
Hodgkin's lymphoma
TT11X
Headline: 
Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma
snippet: 

78% Overall Response Rate (14/18 patients), including seven patients exhibiting a complete response to TT11X allogeneic CAR-T therapy

Do Not Allow Advertisers to Use My Personal information